Nippon India Pharma Fund-Growth Plan-Growth Option

(Erstwhile Reliance Pharma Fund-Growth Plan-Growth Option)
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 01-06-2004
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.15% As on (31-01-2020)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 2,421.07 Cr As on (29-02-2020)
Turn over: 16% | Exit Load: For units in excess of 10% of the investment,1% will be charged for redemption within 365 days

164.7321

19.33%

PERFORMANCE

Returns Type:
of  
Start :  
End : 
Period:  
This Scheme
-
vs
S&P BSE Healthcare TRI
-
Gold
-
PPF
-
Returns Type:
of  
  Period:  

Start :  
Period:  

RETURNS ANALYSIS

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

Time Taken To Multiply
2x
4x
5x
10x
FUND
1 Years 8 Months
5 Years 6 Months
6 Years 0 Months
10 Years 1 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months

 

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Current Asset Allocation (%)

Indicators

Volatility 15.77
Sharp Ratio -0.02
Alpha 1.92
Beta 0.84
Yield to Maturity -
Average Maturity -

PEER COMPARISON

Scheme Name Inception
Date
1 Year
Return(%)
2 Year
Return(%)
3 Year
Return(%)
5 Year
Return(%)
10 Year
Return(%)
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 9.24 9.28 6.73 2.42 12.89
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 16.86 - - - -
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 15.92 - - - -
Mirae Asset Healthcare Fund -Regular Growth 20-07-2018 15.03 - - - -
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 14.43 9.56 4.19 - -
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 9.98 - - - -
UTI Healthcare Fund - Regular Plan - Growth Option 01-08-2005 7.97 4.66 1.11 -2.81 10.34
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 14-07-1999 7.78 3.83 -1.81 -3.23 13.01
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 - - - - -

Scheme Characteristics

Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.

Riskometer

riskometer

PORTFOLIO

Market Cap Distribution

Small Cap

13.49%

Others

-0.01%

Large Cap

53.7%

Mid Cap

32.82%

Tax Benefits of investing in this fund

Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#

Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.

Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **

# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund

Feedback